Our Therapies
Cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) Infusion Therapy
Meet our Infusion Specialists
Jalal Thwainey M.D.
Medical Director
Emilie Wojcik, N.P.
Director of Clinical Services
For Provider
Simplify patient referrals and offer advanced treatment options with our infusion partnership program.
For Patient
There may be a better way to manage your condition – explore infusion therapy.